首页/数据集/A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

NIAID Data Ecosystem2026-03-13 收录

肿瘤免疫治疗预后预测

miRNA生物标志物

数据链接：

https://www.ncbi.nlm.nih.gov/sra/ERP135083 数据链接链接失效反馈

官方服务：

资源简介：

Whole blood, small RNA expression profiles from a total of 334 stage IV NSCLC patients were analysed. This data was used to train models to predict overall survival following immunotherapy.

应用场景：

创建时间：

2022-02-06

神经内分泌肿瘤分子分型

miRNA生物标志物

Neuroendocrine neoplasms (NENs) are clinically diverse and incompletely characterized cancers that are challenging to classify. MicroRNAs (miRNAs) are small regulatory RNAs that can be used to classif

DataONE2020-06-16 更新70

Table_1_Integrative Analysis of the Genomic and Immune Microenvironment Characteristics Associated With Clear Cell Renal Cell Carcinoma Progression: Implications for Prognosis and Immunotherapy.xlsx

ccRCC免疫基因组分析

肿瘤免疫治疗预后预测

Unlike early clear cell renal cell carcinoma (ccRCC), locally advanced and metastatic ccRCC present poor treatment outcomes and prognosis. As immune checkpoint inhibitors have achieved favorable resul

NIAID Data Ecosystem30

Circulating miRNA signature in serum of pateints with primary sclerosing cholangitis (PSC), cholangiocarcinoma (CC) and healthy controls.

miRNA生物标志物

胆管癌与原发性硬化性胆管炎鉴别诊断

RNA was isolated from serum of pateints with PAS, CC and healthy controls. Global microRNA profiling was done using miRNome microRNA Profiler QuantiMir Human PCR Array (#RA660A-1, version 15; BioCat,

NIAID Data Ecosystem20

Plasma circulating MiRNAs: a new potential biomarker for prostate cancer diagnosis.. Plasma circulating MiRNAs: a new potential biomarker for prostate cancer diagnosis.

前列腺癌诊断

miRNA生物标志物

Purpose: PCa is the second most commonly diagnosed malignancy in men. PCa Diagnosis are based on biopsy sampling that is an invasive, expensive procedure and does not accurately represent multifocal d

NIAID Data Ecosystem50

Table_3_Establishment of a 4-miRNA Prognostic Model for Risk Stratification of Patients With Pancreatic Adenocarcinoma.xlsx

癌症预后预测

miRNA生物标志物

Pancreatic adenocarcinomas (PAADs) often remain undiagnosed until later stages, limiting treatment options and leading to poor survival. The lack of robust biomarkers complicates PAAD prognosis, and p

NIAID Data Ecosystem20

A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy

资源简介：

相关数据集